You are here


FHI 360 launches FHI Clinical as a full-service contract research organization

April 09, 2019

FHI 360 announces the launch of FHI Clinical, Inc., a full-service contract research organization (CRO) with the global expertise, responsive approaches and proven solutions to manage complex clinical research in resource-limited settings around the world.

With a focus on mission-driven clinical research, FHI Clinical addresses unmet research needs across dozens of therapeutic areas and supports the development of lifesaving vaccines and medicines. Whether working from a state-of-the-art facility or in a low-tech, rural setting, FHI Clinical provides services tailored to meet its clients’ diverse study needs, from protocol design and site assessment to trial planning, implementation and management.

FHI Clinical is led by Ted FitzGerald, who transitions from Director of Global Research Services (GRS), FHI 360, to President and Chief Executive Officer of the new company. Over a decade of work for FHI 360, FitzGerald led clinical research services, business development and administrative teams.

FHI Clinical operates as an independent, commercial subsidiary of FHI 360, an international nonprofit working to improve the health and well-being of people in the United States and around the world. The company benefits from FHI 360’s nearly 50-year history of research and its past successes creating and growing CROs. FHI Clinical is headquartered in downtown Durham, North Carolina.

“FHI 360’s global reach and reputation for excellence has enabled us to provide technical, regulatory and cultural expertise in regions where the needs for clinical research are greatest,” said FitzGerald. “As an independent subsidiary, FHI Clinical has the best of both worlds — access to FHI 360’s global platform and technical expertise and the flexibility to implement systems and processes designed for both commercial and public sector clients.”

FHI Clinical joins FHI 360’s family of organizations, which includes two other recently launched subsidiaries: the social impact investing company FHI Ventures and the nonprofit FHI Partners, which creates strategic partnerships with foundations and corporations.

“FHI Clinical will enable us to further expand our social impact,” said Patrick Fine, Chief Executive Officer of FHI 360. “Each member of the FHI 360 family operates differently, yet together we are guided by the same vision: to create a world in which all individuals and communities have the opportunity to reach their highest potential. I’m confident that FHI Clinical will deliver on that mission.”